Picture of Mirum Pharmaceuticals logo

MIRM Mirum Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Mirum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-84-136-163-87.9-23.4
Depreciation
Deferred Taxes
Non-Cash Items-66.339.91045274.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital17-21.1-22.622.6-19.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-133-120-70.910.355.8
Capital Expenditures-19-0.278-20.1-21-0.954
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items67.67.98-87.1-69.1-23
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities48.57.7-107-90.1-24
Financing Cash Flow Items64.5-5.55-19600
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities73.510933717.740.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10.7-3.34158-63.475.2